Recent reports"
have described successful production of pancreatic glucagon-specific antisera with the C-terminal tryptic fragment of porcine glucagon, glucagon (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) , as immunogen. One of the antisera, OAL-123, was efficiently used for development of a radioimmunoassay as a tool for measuring pancreatic glucagon in biologic fluids and tissue extracts2),4). Trypsin-catalyzed digestion of porcine glucagon, however, resulted in the formation of a mixture of products and extensive purification was required for preparation of the homogeneous glucagon (19-29) as immunogen1). Alternatively, we have attempted to synthesize undecapeptide corresponding to the amino acid sequence of glucagon (19-29) 5). The undecapeptide, H-AIaGln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH, thus obtained in high yield, was proved to be homogenous and has been used for production of the C-terminal specific glucagon antisera. This communication provides evaluation of a glucagon radioimmunoassay with use of antiserum raised against synthetic undecapeptide corresponding to the 19-29 sequence of human glucagon.
Materials and Methods
Synthesis of H-AIa-GIn-Asp-Phe-Val-GlnTrp-Leu-Met-Asn-Thr-OH (human glucagon The azide derived from III, which was constructed in the manner shown in Scheme III, was then coupled with IV to obtain the protected undecapeptide.
Protected peptide intermediates were purified by precipitation from suitable solvent or by countercurrent distribution and the Boc group was then removed with trifluoroacetic acid (TFA) containing ethane dithiol6).
The final coupling product, protected undeca- mately 15 pg/ml. Intra-and interassay variability of this assay system was examined using 3 different human plasma samples of different immunoreactive glucagon concentrations. As shown in Table 1 and 2, the intra-and interassay coefficients of variation ranged from 1.9 to 5.5% and from 1.5 to 6.4%, respectively.
Analytical recovery
was tested by adding standard glucagon to 3 different plasma samples.
The mean recovery was 94.4, 99.6 and 99.3%, respectively, as shown in Table 3 . Dilution test was carried out using 2 plasma samples. As shown in Fig. 3 , a linear dilution curve was obtained in each case. 
